Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT07039916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Mild to Severe Generalized Myasthenia Gravis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
Study identification
- NCT ID
- NCT07039916
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 231 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2025 (Actual)
- Primary completion
- Dec 2027 (Estimated)
- Completion
- Dec 2028 (Estimated)
- Last update posted
- Jul 30, 2026
2025 – 2028
United States locations
- U.S. sites
- 48
- U.S. states
- 25
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Number - 1056 | Huntsville | Alabama | 35801 | Recruiting |
| Site Number - 1041 | Mobile | Alabama | 36604 | Recruiting |
| Site Number - 1017 | Phoenix | Arizona | 85028 | Recruiting |
| Site Number - 1025 | Scottsdale | Arizona | 85251 | Recruiting |
| Site Number - 1042 | Tucson | Arizona | 85718 | Recruiting |
| Site Number - 1010 | Carlsbad | California | 92011 | Recruiting |
| Site Number - 1028 | Irvine | California | 92697 | Recruiting |
| Site Number - 1023 | Los Angeles | California | 90033 | Recruiting |
| Site Number - 1029 | Rancho Mirage | California | 92270 | Recruiting |
| Site Number - 1004 | San Francisco | California | 94143 | Recruiting |
| Site Number - 1027 | Fort Collins | Colorado | 80528 | Recruiting |
| Site Number - 1001 | New Haven | Connecticut | 06510 | Recruiting |
| Site Number - 1024 | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Site Number - 1006 | Clearwater | Florida | 33761 | Recruiting |
| Site Number - 1037 | Ormond Beach | Florida | 32174 | Recruiting |
| Site Number - 1002 | Port Charlotte | Florida | 33952 | Recruiting |
| Site Number - 1050 | Rockledge | Florida | 32955 | Recruiting |
| Site Number - 1007 | Tampa | Florida | 33612 | Recruiting |
| Site Number - 1014 | Atlanta | Georgia | 30329 | Recruiting |
| Site Number - 1043 | Augusta | Georgia | 30912 | Recruiting |
| Site Number - 1054 | Schaumburg | Illinois | 60173 | Recruiting |
| Site Number - 1022 | Lexington | Kentucky | 40536-0284 | Recruiting |
| Site Number - 1032 | Nicholasville | Kentucky | 40356 | Recruiting |
| Site Number - 1046 | New Orleans | Louisiana | 70121 | Recruiting |
| Site Number - 1049 | Foxborough | Massachusetts | 02035 | Recruiting |
| Site Number - 1026 | Detroit | Michigan | 48201 | Recruiting |
| Site Number - 1005 | East Lansing | Michigan | 48824 | Recruiting |
| Site Number - 1018 | Omaha | Nebraska | 68198 | Recruiting |
| Site Number - 1019 | Totowa | New Jersey | 07512 | Recruiting |
| Site Number - 1036 | New York | New York | 10021 | Recruiting |
| Site Number - 1034 | New York | New York | 10065 | Recruiting |
| Site Number - 1020 | Chapel Hill | North Carolina | 27599 | Recruiting |
| Site Number - 1013 | Durham | North Carolina | 27710 | Recruiting |
| Site Number - 1044 | Raleigh | North Carolina | 27607 | Recruiting |
| Site Number - 1038 | Cincinnati | Ohio | 45221 | Recruiting |
| Site Number - 1045 | Oklahoma City | Oklahoma | 73104 | Recruiting |
| Site Number - 1011 | Yukon | Oklahoma | 73099 | Recruiting |
| Site Number - 1031 | Eugene | Oregon | 97477 | Recruiting |
| Site Number - 1030 | Charleston | South Carolina | 29425 | Recruiting |
| Site Number - 1015 | Charleston | South Carolina | 29486 | Recruiting |
| Site Number - 1021 | Memphis | Tennessee | 38120 | Recruiting |
| Site Number - 1003 | Dallas | Texas | 75206 | Recruiting |
| Site Number - 1047 | Denton | Texas | 76208 | Recruiting |
| Site Number - 1057 | Houston | Texas | 77054 | Recruiting |
| Site Number - 1048 | Lubbock | Texas | 79414 | Recruiting |
| Site Number - 1009 | Charlottesville | Virginia | 22903 | Recruiting |
| Site Number - 1040 | Richmond | Virginia | 23298 | Recruiting |
| Site Number - 1035 | Greenfield | Wisconsin | 53228 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07039916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07039916 live on ClinicalTrials.gov.